rs58212659
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_021098.3(CACNA1H):c.2145C>T(p.Ser715Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000479 in 1,612,336 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0020 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00032 ( 0 hom. )
Consequence
CACNA1H
NM_021098.3 synonymous
NM_021098.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.11
Publications
2 publications found
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 16-1204152-C-T is Benign according to our data. Variant chr16-1204152-C-T is described in ClinVar as Benign. ClinVar VariationId is 529684.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.11 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00202 (308/152356) while in subpopulation AFR AF = 0.00695 (289/41584). AF 95% confidence interval is 0.00629. There are 2 homozygotes in GnomAd4. There are 149 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 308 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CACNA1H | NM_021098.3 | c.2145C>T | p.Ser715Ser | synonymous_variant | Exon 10 of 35 | ENST00000348261.11 | NP_066921.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.2145C>T | p.Ser715Ser | synonymous_variant | Exon 10 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | c.2145C>T | p.Ser715Ser | synonymous_variant | Exon 10 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1 | c.2145C>T | p.Ser715Ser | synonymous_variant | Exon 10 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7 | c.2145C>T | p.Ser715Ser | synonymous_variant | Exon 10 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1 | c.2145C>T | p.Ser715Ser | synonymous_variant | Exon 10 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6 | c.2145C>T | p.Ser715Ser | synonymous_variant | Exon 10 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1 | c.2106C>T | p.Ser702Ser | synonymous_variant | Exon 10 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6 | c.2145C>T | p.Ser715Ser | synonymous_variant | Exon 10 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1 | c.2106C>T | p.Ser702Ser | synonymous_variant | Exon 10 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1 | c.2145C>T | p.Ser715Ser | synonymous_variant | Exon 10 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1 | c.2145C>T | p.Ser715Ser | synonymous_variant | Exon 10 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1 | c.2145C>T | p.Ser715Ser | synonymous_variant | Exon 10 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1 | c.2145C>T | p.Ser715Ser | synonymous_variant | Exon 10 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1 | c.2145C>T | p.Ser715Ser | synonymous_variant | Exon 10 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2 | n.2145C>T | non_coding_transcript_exon_variant | Exon 10 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.2145C>T | non_coding_transcript_exon_variant | Exon 10 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.2145C>T | non_coding_transcript_exon_variant | Exon 10 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.*58C>T | non_coding_transcript_exon_variant | Exon 10 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*1592C>T | non_coding_transcript_exon_variant | Exon 9 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.2145C>T | non_coding_transcript_exon_variant | Exon 10 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.2145C>T | non_coding_transcript_exon_variant | Exon 10 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.2145C>T | non_coding_transcript_exon_variant | Exon 10 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.2145C>T | non_coding_transcript_exon_variant | Exon 10 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.2145C>T | non_coding_transcript_exon_variant | Exon 10 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.2145C>T | non_coding_transcript_exon_variant | Exon 10 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.2145C>T | non_coding_transcript_exon_variant | Exon 10 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.2145C>T | non_coding_transcript_exon_variant | Exon 10 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.2145C>T | non_coding_transcript_exon_variant | Exon 10 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000640028.1 | n.*58C>T | 3_prime_UTR_variant | Exon 10 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.*1592C>T | 3_prime_UTR_variant | Exon 9 of 34 | ENSP00000518758.1 |
Frequencies
GnomAD3 genomes AF: 0.00202 AC: 307AN: 152238Hom.: 2 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
307
AN:
152238
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000587 AC: 144AN: 245276 AF XY: 0.000529 show subpopulations
GnomAD2 exomes
AF:
AC:
144
AN:
245276
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000318 AC: 464AN: 1459980Hom.: 0 Cov.: 32 AF XY: 0.000285 AC XY: 207AN XY: 726264 show subpopulations
GnomAD4 exome
AF:
AC:
464
AN:
1459980
Hom.:
Cov.:
32
AF XY:
AC XY:
207
AN XY:
726264
show subpopulations
African (AFR)
AF:
AC:
301
AN:
33474
American (AMR)
AF:
AC:
21
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
AC:
24
AN:
26120
East Asian (EAS)
AF:
AC:
2
AN:
39684
South Asian (SAS)
AF:
AC:
3
AN:
86230
European-Finnish (FIN)
AF:
AC:
0
AN:
52016
Middle Eastern (MID)
AF:
AC:
1
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
83
AN:
1111690
Other (OTH)
AF:
AC:
29
AN:
60312
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
28
55
83
110
138
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00202 AC: 308AN: 152356Hom.: 2 Cov.: 33 AF XY: 0.00200 AC XY: 149AN XY: 74508 show subpopulations
GnomAD4 genome
AF:
AC:
308
AN:
152356
Hom.:
Cov.:
33
AF XY:
AC XY:
149
AN XY:
74508
show subpopulations
African (AFR)
AF:
AC:
289
AN:
41584
American (AMR)
AF:
AC:
11
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5178
South Asian (SAS)
AF:
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2
AN:
68034
Other (OTH)
AF:
AC:
4
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
18
37
55
74
92
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 08, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jan 19, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.